Including Financial Protection and Equity in Health CEAs
Upcoming SlideShare
Loading in...5
×
 

Including Financial Protection and Equity in Health CEAs

on

  • 348 views

GHME 2013 Conference ...

GHME 2013 Conference
Session: New directions in cost-effectiveness analysis
Date: June 16 2013
Presenter: Dean Jamison
Institute:
Center for Disease Dynamics, Economics & Policy
University of Washington Department of Global Health

Statistics

Views

Total Views
348
Views on SlideShare
348
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Including Financial Protection and Equity in Health CEAs Including Financial Protection and Equity in Health CEAs Presentation Transcript

  • www.dcp-3.org info@dcp-3.org Including Financial Protection and Equity in Health CEAs Dean T. Jamison University of Washington, Department of Global Health Global Health Metrics and Evaluation Conference June 16, 2013 17/18/2013
  • Plan for this Talk • Conceptual background • Public finance of TB treatment of India 7/18/2013 2
  • Outcomes of a Policy 7/18/2013 3 • Health gains (burden of disease averted) • Financial protection benefits (“insurance” to households from medical impoverishment) • Income consequences for households • Distributional consequences (across income groups, ethnic subgroups or between males and female)
  • Evaluation of Policy: Extended Cost-Effectiveness Analysis (ECEA) 7/18/2013 4 • Evaluation of interventions and platforms (CEA) (e.g. DOTS as an intervention surgical capacity at a district hospital as a platform) • Evaluation of Policies
  • Policies • Taxes and subsidies (e.g. universal public finance; tobacco taxes) • Laws and regulation • Investment in capacity • Information and education 7/18/2013 5
  • Financial Risk Protection 1 • Enthoven (1987) stressed importance of FRP as a health system objective. • Metrics include: • Incidence of impoverishment, excessive spending, forced borrowing and forced asset sales (Wagstaff reviews results) • Money-metric value of insurance 7/18/2013 6
  • Financial Risk Protection (2) Insurance 7/18/2013 7 • Risk aversion Individuals value protection from the risk of uncertain adverse events y = individual income r = coefficient of relative risk aversion • Approach consistent with recent work McClellan & Skinner. The incidence of Medicare. Journal of Public Economics 2006 Smith. Incorporating financial protection into the economic evaluation of health technologies. Health Economics 2012
  • 7/18/2013 8 Financial Risk Protection (3) • Money-metric value of insurance provided Gamble with: - disease occurs at incidence p (depending on income) - has treatment cost c • For 1 individual, money-metric value of insurance = expected value - certainty equivalent of gamble
  • ECEA Structure 7/18/2013 9 Policy Instrument Health gains (e.g. TB deaths averted) Household expenditures (e.g. TB-related costs averted) “Insurance” benefits (e.g. financial protection from TB-related costs) Poorest 2nd Poorest Middle 2nd Richest Richest
  • Universal public finance of TB treatment in India Work undertaken with Stéphane Verguet and Ramanan Laxminarayan 7/18/2013 10
  • Tuberculosis in India 7/18/2013 11 • TB epidemiology Annual incidence of 100 per 100,000 (sputum smear-positives) (WHO 2012) 4 times higher incidence among the poor (Muniyandi et al. 2007) Case fatality rate of untreated case 0.32 (WHO 2012) • TB treatment (DOTS) Cost of $100 per patient Effective at 90% (WHO 2012) • Current DOTS coverage - average of 71% - bottom income quintile: 47% - top income quintile: 95%
  • UPF for TB Treatment Over 1 Year for 1 Million Indians 7/18/2013 12 TB deaths averted Poorest 2nd Poorest Middle 2nd Richest Richest Treat TB-infected with DOTS DOTS coverage (~ 90%) DOTS effectiveness (~ 90%) TB costs averted for households Financial protection benefits
  • Benefits over 1 Year with UPF for 90% coverage of TB Treatment (per million population) 7/18/2013 13 Outcome Total Income Quintile I (Poorest) Income Quintile II (Poorer) Income Quintile III (Middle) Income Quintile IV (Richer) Income Quintile V (Richest) 1 TB deaths averted 80 40 25 12 3 0 2 Private expenditures crowded out $29,000 6,000 6,000 7,000 6,000 4,000 3 Money- metric value of insurance $9,000 5,000 2,000 1,000 1,000 0 Total cost of public program of $65,000
  • Coping Mechanisms: Borrowing 7/18/2013 14 • Without UPF, when faced with costly treatment, the poor borrow from peers or sell assets • 50% of poor households in India borrow money/sell assets at high interest rates (Kruk et al. 2009) • Assume the poor take a loan over 10 years at annual interest rate of 20% to subsidize TB treatment
  • Benefits over 1 Year for 1 Million Indians with UPF for TB Treatment 7/18/2013 15 Outcome Total Income Quintile I (Poorest) Income Quintile II (Poorer) Income Quintile III (Middle) Income Quintile IV (Richer) Income Quintile V (Richest) 1 TB deaths averted 150 100 50 0 0 0 2 Private expenditures crowded out $70,000 0 15,000 25,000 20,000 10,000 3 Money- metric value of insurance $10,000 0 3,000 4,000 2,000 1,000 Total cost of public program of $130,000
  • Comparative Analysis – Ethiopia Stéphane Verguet, Zachary Olson, Joseph Babigumira, Margaret Kruk, Kjell Arne Johansson, Carol Levin, Rachel Nugent, Clint Pecenka, Mark Shrime, David Watkins, Dean Jamison 7/18/2013 16
  • Ethiopia 7/18/2013 17
  • 7/18/2013 18 Thank you Contact Information: Djamison@uw.edu